NEW YORK (Reuters) - Pfizer Inc and BioNTech's COVID-19 vaccine appeared to lose only a small bit of effectiveness against an engineered virus with three key mutations from the new coronavirus variant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results